Abivax (AAVXF) Selling, General & Administrative (2022 - 2026)
Powered by 
Analysis
Abivax (AAVXF) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | 165.53 Mn |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | -7.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -7.36 Mn |
| Dec 31, 2025 | -30.11 Mn |
| Sep 30, 2025 | -29.81 Mn |
| Jun 30, 2025 | -9.36 Mn |
| Mar 31, 2025 | -8.45 Mn |
| Dec 31, 2024 | -35.16 |
| Sep 30, 2024 | -8.10 Mn |
| Jun 30, 2024 | -10.55 Mn |
| Mar 31, 2024 | -8.84 Mn |
| Dec 31, 2023 | -24.10 |
| Dec 31, 2022 | -7.65 |